at University of Helsinki
Full TimeWe are seeking a qualified and motivated postdoctoral fellow with background in population genetics for national and international research projects of the Human Genomics Unit at FIMM led by Professors Samuli Ripatti and Aarno Palotie.
Role description:
As member of an international, multidisciplinary team of experts in genomics, IT, Clinical Medicine, and Social Sciences within the TeamPerMed consortium, the postdoctoral fellow will develop and apply novel tools for genetic and clinical risk prediction, utilizing the biobank-scale data resources within TeamPerMed. The overarching goal of the project is to empower University of Tartu together with Tartu University Hospital in collaboration with FIMM and Dept of computer science at University of Helsinki, and Erasmus University in Rotterdam, Netherlands, to form the independent Center for Personalized Medicine. As member of the TeamPermed consortium, the candidate is expected to develop her/his own project with new research questions and using tools that will later support the launch of an ambitious independent career.
A certain amount of traveling will be required and there are opportunities for research visits between TeamPerMed partners.
Key requirements:
We are looking for a highly motivated and creative person with strong data science background and interest in working on genetic research questions to benefit population health and personalized medicine. The ideal candidate is capable of working in multidisciplinary international teams of clinical researchers, statistical geneticists, data scientists and molecular biologists. Candidates should have a PhD in data sciences, or in medicine, molecular biology or related field with experience in bioinformatics and genetics.
The candidate should have fluency in written and spoken English (knowledge of Finnish or other European language will be an advantage).
Professor Samuli Ripatti, PhD, is the Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE, Professor of Biometry at the Faculty of Medicine, University of Helsinki and affiliated faculty at Massachusetts General Hospital and Broad Institute of MIT and Harvard. He is chairing the Academy of Finland Centre of Excellence in Complex Disease Genetics and EU H2020-funded Intervene Consortium. His research group studies genetic variation in the Finnish population and its effects on common complex disease risks and management. He is one of the pioneers in developing and testing the clinical translation of polygenic risk scores in disease prevention and early detection.
Professor Aarno Palotie, M.D., Ph.D. is the Research Director of the Human Genomics program at the Institute for Molecular Medicine Finland (FIMM), HiLIFE and Scientific Director of FinnGen project. He is also a faculty member at the Center for Human Genome Research at the Massachusetts General Hospital in Boston and an associate member of the Broad Institute of MIT and Harvard
This is a full-time position based in Biomedicum 2, Helsinki (www.biomedicum.fi), Finland, and is expected to start on February 01, 2025, or earlier for an initial period of at least two years with a possibility of extension.
Salary will be based on the University salary scheme for research and teaching staff. Scheme level depends on the candidate’s qualifications.
To apply for the position, please send your motivation letter and CV, including list of publications and contact information for two references, through the University of Helsinki electronic recruitment system by clicking on the Apply link. Internal applicants (i.e., current employees of the University of Helsinki) please submit your applications through the SAP Fiori portal.
Please apply no later than November 30, 2024. The employment may begin as soon as possible or as agreed.
For further information please visit our website at http://www.fimm.fi and/or contact Professor Samuli Ripatti samuli.ripatti(at)helsinki.fi, or Project coordinator sari.kivikko(at)helsinki.fi.
Institute for Molecular Medicine Finland
The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalised medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki - a leading Nordic university with a strong commitment to life science research. As part of Academic Medical Center Helsinki in Meilahti campus FIMM collaborates locally with the Faculty of Medicine, Helsinki University Hospital and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community
The University of Helsinki welcomes applicants of any gender and age, linguistic or cultural background, or minority group.
Click this link to read about accessibility and inclusivity at our University.
JOIN US TO BUILD A BETTER WORLD – TOGETHER!
#HelsinkiUniCareers
